These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4421385)

  • 1. [Purinor in the treatment of porphyria cutanea tarda].
    Capusan I; Opincaru E; Bociat T; Lazar V; Moisi IG
    Z Hautkr; 1974 Jul; 49(13):575-8. PubMed ID: 4421385
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pyridoxal-5-phosphate in porphyria cutanea tarda].
    Vibrans U; Hilgenfeldt J; Petres J
    Hautarzt; 1972 Apr; 23(4):155-60. PubMed ID: 5048343
    [No Abstract]   [Full Text] [Related]  

  • 3. Porphyria cutanea tarda treated with chloroquine phosphate.
    Bloom M
    Arch Dermatol; 1969 Sep; 100(3):375-6. PubMed ID: 5822385
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of porphyria cutanea tarda with chloroquine.
    Kordac V; Semrádová M
    Br J Dermatol; 1974 Jan; 90(1):95-100. PubMed ID: 4811840
    [No Abstract]   [Full Text] [Related]  

  • 5. [Examination of the activity of AP, LDH, GOT, gamma GT and LAP in the serum of patients with porphyria cutanea tarda].
    Simon N; Sohár I; Berkó G; Varga L
    Dermatol Monatsschr; 1977 Jan; 163(1):36-40. PubMed ID: 838104
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of porphyria cutanea tarda by venesection.
    Ramsay CA; Magnus IA; Turnbull A; Baker H
    Q J Med; 1974 Jan; 43(169):1-24. PubMed ID: 4822971
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of porphyria cutanea tarda with intermittent chloroquine].
    Raff M; Formanek I
    Hautarzt; 1980 Aug; 31(8):437-40. PubMed ID: 7451150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some observations on the treatment of porphyrias with CaEDTA.
    Roman W
    Enzymologia; 1967 Jan; 32(1):37-82. PubMed ID: 4988030
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of diseases of liver parenchyma; experiences with intravenous injections of a preparation containing a mixture of orotic acid and purines].
    BECKMANN K; BRUGEL H; MERTZ DP
    Dtsch Med Wochenschr; 1956 Apr; 81(15):573-7. PubMed ID: 13317662
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on low dose chloroquine therapy and the action of chloroquine in symptomatic porphyria.
    Taljaard JJ; Shanley BC; Stewart-Wynne EG; Deppe WM; Joubert SM
    Br J Dermatol; 1972 Sep; 87(3):261-9. PubMed ID: 5080345
    [No Abstract]   [Full Text] [Related]  

  • 11. [Problem of active therapeutic procedure in chronic liver disease].
    Chlumský J; Hyncík V
    Cas Lek Cesk; 1972 Aug; 111(32):737-40. PubMed ID: 5052534
    [No Abstract]   [Full Text] [Related]  

  • 12. [Significance of orotic acid and purine bases in the prevention of decompensation of the hyperthrophic heart].
    Belen'kiĭ EE; Pogosova AV; Tunitskaia TA
    Farmakol Toksikol; 1968; 31(3):273-7. PubMed ID: 4235231
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experience report on Hepavis].
    Menninger U; Menninger W
    Med Welt; 1980 Oct; 31(42):1519-21. PubMed ID: 7453534
    [No Abstract]   [Full Text] [Related]  

  • 14. [Results of clinical and chemical studies in porphyria cutanea tarda].
    Formanek I; Niebauer G
    Wien Z Inn Med; 1966 Nov; 47(11):438-44. PubMed ID: 6005177
    [No Abstract]   [Full Text] [Related]  

  • 15. Porphyria cutanea tarda treated with sodium bicarbonate.
    Burrows D
    Br J Dermatol; 1972 Feb; 86(2):200. PubMed ID: 5017294
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serum enzyme activities in hepatic porphyria. A comparison of the changes in porphyria cutanea tarda and in experimental porphyria of the rat].
    Raab W; Pietschmann H
    Klin Wochenschr; 1967 Jun; 45(11):587-8. PubMed ID: 5593556
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of patients with porphyria cutanea tarda with antimalarials].
    Kordac V; Semrádová M
    Cas Lek Cesk; 1973; 112(24):762-5. PubMed ID: 4714507
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical and biological effects of chelating agents in porphyria cutanea tarda].
    Thivolet J; Perrot H; Mallein R; Sabater P
    Presse Med (1893); 1968 Feb; 76(8):367-70. PubMed ID: 4967022
    [No Abstract]   [Full Text] [Related]  

  • 19. The therapeutic effect of chloroquine. Hepatic recovery in porphyria cutanea tarda.
    Kowertz MJ
    JAMA; 1973 Jan; 223(5):515-9. PubMed ID: 4739135
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolic alkalinization therapy in porphyria cutanea tarda.
    Perry HO; Mullanax MG; Wiegand SE
    Arch Dermatol; 1970 Oct; 102(4):359-67. PubMed ID: 5470946
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.